High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$695K
$695,240
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
STOK
S
Stoke Therapeutics, Inc.
Allan Jonathan
• Officer • GENERAL COUNSEL & CORP SEC
Sell to Cover
2025-12-05
$274,898x3
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • GENERAL COUNSEL & CORP SEC
Sell to Cover
|
2025-12-05 | $274,898x3 | S | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Allan Jonathan
• Officer • GENERAL COUNSEL & CORP SEC
Sell to Cover
2025-12-04
$31,425x2
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • GENERAL COUNSEL & CORP SEC
Sell to Cover
|
2025-12-04 | $31,425x2 | S | Form 4 |
|
STOK
M
Stoke Therapeutics, Inc.
Allan Jonathan
• Officer • GENERAL COUNSEL & CORP SEC
Equity Compensation
2025-12-03
$0
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • GENERAL COUNSEL & CORP SEC
Equity Compensation
|
2025-12-03 | $0 | M | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Allan Jonathan
• Officer • GENERAL COUNSEL & CORP SEC
Sell to Cover
2025-12-03
$70,245x2
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • GENERAL COUNSEL & CORP SEC
Sell to Cover
|
2025-12-03 | $70,245x2 | S | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Allan Jonathan
• Officer • GENERAL COUNSEL & CORP SEC
Sell to Cover
2025-12-02
$68,023x2
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • GENERAL COUNSEL & CORP SEC
Sell to Cover
|
2025-12-02 | $68,023x2 | S | Form 4 |
|
STOK
M
Stoke Therapeutics, Inc.
Allan Jonathan
• Officer • GENERAL COUNSEL & CORP SEC
Equity Compensation
2025-12-01
$0
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • GENERAL COUNSEL & CORP SEC
Equity Compensation
|
2025-12-01 | $0 | M | Form 4 |
|
STOK
M
Stoke Therapeutics, Inc.
Allan Jonathan
• Officer • GENERAL COUNSEL & CORP SEC
Other
2025-10-03
$91,500
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • GENERAL COUNSEL & CORP SEC
Other
|
2025-10-03 | $91,500 | M | Form 4 |
|
STOK
S
Stoke Therapeutics, Inc.
Allan Jonathan
• Officer • GENERAL COUNSEL & CORP SEC
10b5-1 SellΔOwn -45.8%
2025-10-03
$250,650
|
||||||
| STOK |
Stoke Therapeutics, Inc.
|
Officer • GENERAL COUNSEL & CORP SEC
10b5-1 SellΔOwn -45.8%
|
2025-10-03 | $250,650 | S | Form 4 |